FY18
Assets1.83
Net Worth0.92
Total Debt0.01
RevenueAnnualised basis0.09
EBITDAAnnualised basis0.07
PATAnnualised basis[●]
EBITDA Margin (%)77.78
At a glance
Updated 2026-09-06Novateor Research Laboratories Ltd is an IPO with an issue size of ₹4.49 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹4.49 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets4.31₹ Cr · +128.0% vs prior year
Net Worth4.07₹ Cr · +342.4% vs prior year
FY17
Assets1.89
Net Worth0.92
Total Debt0.04
RevenueAnnualised basis0.13
EBITDAAnnualised basis0.07
PATAnnualised basis[●]
EBITDA Margin (%)53.85
31-Mar-19
Assets4.31
Net Worth4.07
Total Debt0.01
RevenueAnnualised basis0.40
EBITDAAnnualised basis0.39
PATAnnualised basis0.21
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Novateor Research Laboratories Ltd IPO | — | 52.00 x | — | — |
| H. R. IPO | — | 17.53 x | — | — |
| Ravelcare Limited IPO | — | 13.95 x | — | — |
| Anondita Medicare IPO | — | 15.98 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-06.
IPO UPDATE ALERTS
Register for IPO Updates →Track Novateor Research Laboratories Ltd without missing an update
Register for subscription, GMP, allotment and listing notifications.